Topical steroid abuse: its use as a depigmenting agent.
Abstract
This study was undertaken to document prevalence, motives and observed complications of steroid use as a depigmenting agent amongst African blacks in southeast Nigeria. This practice is very common in the African environment. Consecutive new patients attending the dermatology clinic of the University of Nigeria TeachingHospital, Enugu, from June to December 2004 were recruited. Active substances of products used were determined from packages, while unknown concoctions were analyzed. Chi-squared and Fischer tests were used for statistical analysis, with a significant threshold fixed at 5%. Females aged 18-69 years accounted for 75% (414) of patients. Main topical steroids used by both women and men were class-1 steroids, and these were often compounded with other bleaching products. Median duration of usage was 9 years +/- 1.3. Disorders observed included steroid-induced acne (45.3%), macular hyperpigmentation of face (37.2%), mycoses (40.4%), striae (28.3%), telangiectasis (21.3%), hypertrichosis (13.9%) and diabetes mellitus (2.1%). Duration of utilization of these topical steroids was significantly associated with severe local and systemic consequences, while withdrawal of the offending steroids usually resulted in severe withdrawal dermatitis that was unpleasant to patients. This may suggest that discontinuation is impossible.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.8M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Findlay GH, Morrison JG, Simson IW. Exogenous ochronosis and pigmented colloid milium from hydroquinone bleaching creams. Br J Dermatol. 1975 Dec;93(6):613–622. [PubMed] [Google Scholar]
- Solomon BA, Glass AT, Rabbin PE. Tinea incognito and "over-the-counter" potent topical steroids. Cutis. 1996 Oct;58(4):295–296. [PubMed] [Google Scholar]
- Harris DW, Hunter JA. The use and abuse of 0.05 per cent clobetasol propionate in dermatology. Dermatol Clin. 1988 Oct;6(4):643–647. [PubMed] [Google Scholar]
- Keane FM, Munn SE, Taylor NF, du Vivier AW. Unregulated use of clobetasol propionate. Br J Dermatol. 2001 May;144(5):1095–1096. [PubMed] [Google Scholar]
- Wone I, Tal-Dia A, Diallo OF, Badiane M, Touré K, Diallo I. Prévalence de l'utilisation de produits cosmétiques dépigmentants dans deux quartiers à Dakar (Sénégal). Dakar Med. 2000;45(2):154–157. [PubMed] [Google Scholar]
- Olumide YM. Photodermatoses in Lagos. Int J Dermatol. 1987 Jun;26(5):295–299. [PubMed] [Google Scholar]
- Lawlor F, Ramabala K. Iatrogenic Cushing's syndrome--a cautionary tale. Clin Exp Dermatol. 1984 May;9(3):286–289. [PubMed] [Google Scholar]
- Hogan DJ, Sibley JT, Lane PR. Avascular necrosis of the hips following longterm use of clobetasol propionate. J Am Acad Dermatol. 1986 Mar;14(3):515–517. [PubMed] [Google Scholar]